Recent advances in biotechnologies have led to speculations about enhancing human beings. Many of the moral arguments presented to defend human enhancement technologies have been limited to discussions of their risks and benefits. The author argues that in so far as ethical arguments focus primarily on risks and benefits of human enhancement technologies, these arguments will be insufficient to provide a robust defence of these technologies. This is so because the belief that an assessment of risks and benefits is a sufficient ethical evaluation of these technologies incorrectly presupposes that risk assessments do not involve value judgements. Second, it presupposes a reductionist conception of ethics as merely a risk management instrument. Each of these assumptions separates ethical evaluation from discussion and appraisal of ends and means and thus leaves important—indeed, essential—ethical considerations out of view. Once these problematic assumptions are rejected, it becomes clear that an adequate defence of human enhancement technologies requires more than a simple balance of their risks and benefits.
- human enhancement technologies
- philosophical ethics
- risk–benefit evaluations
- technology/risk assessment
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Competing interests None.
Provenance and peer review Not commissioned; externally peer reviewed.
Read the full text or download the PDF:
Other content recommended for you
- Transhumanism, medical technology and slippery slopes
- Human enhancement and perfection
- Should we enhance animals?
- An evaluative conservative case for biomedical enhancement
- In vitro eugenics
- What is morally salient about enhancement technologies?
- Digital technologies for motor rehabilitation in children: protocol for a cross-sectional European survey
- Enhancement's place in medicine
- On the argument that enhancement is “cheating”
- Reproductive technologies, risk, enhancement and the value of genetic relatedness